Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.
Predictability of B cell clonal persistence and immunosurveillance in breast cancer.
Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.
Converging and evolving immuno-genomic routes toward immune escape in breast cancer.
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG.